News

Stay up to date with our products and technology by reading the most recent news articles.
Sense was named to a Global Top 5 list of Emerging Neurological Device Startups

Sense was named to a Global Top 5 list of Emerging Neurological Device Startups

StartUs Insights analyzed 90 companies before selecting five, with Sense as the sole US representative. Every day, #stroke and brain injury patients suffer disability and death that might have been avoided if they’d gotten to the proper level of care facility sooner. Our team is working tirelessly to develop technology to address this problem and improve outcomes for patients and hospitals.

Sense Diagnostics inks 'know-how' license agreement with Mayo Clinic

Cincinnati Business Courier
December 14, 2022

MedCity INVEST Pitch Perfect Winners

National Healthcare
Investing Event
July 20-24 2020. Virtual Conference.

This Device Looks Inside Your Brain

Cincinnati Public Radio
Jun 19, 2017

The Sensor Evaluation of Neurologic Status in Emergencies (SENSE) Device

American College of Emergency Physicians
May 2017

2017 Health Care Heroes finalist: Dr. Opeolu Adeoye

Cincinnati Business Courier
Feb 23, 2017

Accelerant funds two start-ups up to $250K each

Dayton Daily News
Feb 09, 2017

In a hospital, he’s a mind reader

University of Cincinnati College of Medicine

May, 2016

Cincinnati Health Briefs for April 27

Cincinnati.com
Apr 26, 2016

Certain statements in this release are forward-looking and subject to risks and uncertainties. Actual results may differ materially depending on regulatory review, funding, and other factors.

Copyright Sense Neuro. 2026. All Rights Reserved. Designed by Node

NeuroHawk™ is an investigational device and is not yet cleared or approved by the U.S. Food and Drug Administration (FDA). It is not available for sale or clinical use in the United States. Information provided is for educational and investor purposes only.